Vanda Pharmaceuticals【VNDA】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

4.485

買値

4.48

売値

4.49

出来高

449,533

4.45 日の範囲 4.64

3.87 52 週間の範囲 6.75

時価総額

261.547M

前日終値

4.59

始値

4.57

時刻

4.485

最終取引時間

02:47:44

財務取引量

US$ 2,027,514

VWAP

4.5103

平均取引量 (3 か月)

642,154

発行済株式数

58,316,044

配当利回り

PER

-13.88

1 株当たり利益 (EPS)

-0.32

歳入

198.77M

純利益

-18.9M

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder... Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.vandapharma.com

本社

Wilmington, Delaware, USA

設立

Vanda Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker VNDA. The last closing price for Vanda Pharmaceuticals was US$4.59. Over the last year, Vanda Pharmaceuticals shares have traded in a share price range of US$ 3.87 to US$ 6.75.

Vanda Pharmaceuticals currently has 58,316,044 shares in issue. The market capitalisation of Vanda Pharmaceuticals is US$267.67 million. Vanda Pharmaceuticals has a price to earnings ratio (PE ratio) of -13.88.

Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia

Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.335	-6.95020746888	4.82	4.8703	4.45	706501	4.66857264	CS
4	-0.145	-3.13174946004	4.63	5.19	4.45	605944	4.85819194	CS
12	-0.345	-7.14285714286	4.83	5.19	4.2	642154	4.64496055	CS
26	-0.205	-4.3710021322	4.69	5.545	4.2	638152	4.75067137	CS
52	0.255	6.02836879433	4.23	6.75	3.87	1126302	5.11528493	CS
156	-6.915	-60.6578947368	11.4	12.06	3.295	850305	5.79752235	CS
260	-5.665	-55.8128078818	10.15	21.8627	3.295	716391	8.27818359	CS

VNDA - Frequently Asked Questions (FAQ)

What is the current Vanda Pharmaceuticals share price?

The current share price of Vanda Pharmaceuticals is US$ 4.485

How many Vanda Pharmaceuticals shares are in issue?

Vanda Pharmaceuticals has 58,316,044 shares in issue

What is the market cap of Vanda Pharmaceuticals?

The market capitalisation of Vanda Pharmaceuticals is USD 267.67M

What is the 1 year trading range for Vanda Pharmaceuticals share price?

Vanda Pharmaceuticals has traded in the range of US$ 3.87 to US$ 6.75 during the past year

What is the PE ratio of Vanda Pharmaceuticals?

The price to earnings ratio of Vanda Pharmaceuticals is -13.88

What is the cash to sales ratio of Vanda Pharmaceuticals?

The cash to sales ratio of Vanda Pharmaceuticals is 1.32

What is the reporting currency for Vanda Pharmaceuticals?

Vanda Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Vanda Pharmaceuticals?

The latest annual turnover of Vanda Pharmaceuticals is USD 198.77M

What is the latest annual profit for Vanda Pharmaceuticals?

The latest annual profit of Vanda Pharmaceuticals is USD -18.9M

What is the registered address of Vanda Pharmaceuticals?

The registered address for Vanda Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Vanda Pharmaceuticals website address?

The website address for Vanda Pharmaceuticals is www.vandapharma.com

Which industry sector does Vanda Pharmaceuticals operate in?

Vanda Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
RSLSReShape Lifesciences Inc	US$ 2.45 (579.61%)	207.81M
BIAFbioAffinity Technologies Inc	US$ 1.3399 (415.35%)	422.15M
CSAICloudastructure Inc	US$ 9.295 (109.35%)	40.27M
ICCTiCoreConnect Inc	US$ 4.12 (83.93%)	181.25M
GATEMarblegate Acquisition Corporation	US$ 36.05 (83.83%)	159.59k
GDHGGolden Heaven Group Holdings Ltd	US$ 0.73 (-84.50%)	13.51M
TBHBrag House Holdings Inc	US$ 1.345 (-79.65%)	3.2M
CMBMCambium Networks Corporation	US$ 0.3482 (-50.64%)	1.79M
APTOAptose Biosciences Inc	US$ 1.65 (-47.62%)	521.89k
LPROOpen Lending Corporation	US$ 1.4695 (-46.76%)	12.07M
BIAFbioAffinity Technologies Inc	US$ 1.3399 (415.35%)	422.15M
STSSSharps Technology Inc	US$ 0.02765 (-7.53%)	314.22M
DMNDamon Inc	US$ 0.0125 (-9.42%)	266.26M
RSLSReShape Lifesciences Inc	US$ 2.45 (579.61%)	207.81M
ICCTiCoreConnect Inc	US$ 4.12 (83.93%)	181.25M